Health and Me

Tanya Dutt

Not From The Brain, Scientists Trace Parkinson’s Disease To This Organ In Your Body

For decades, Parkinson's disease has long been thought of as a brain disorder, characterized by the degeneration of dopamine-producing neurons in the substantia nigra — a region of the brain that regulates movement. The loss of these neurons progressively contributes to hallmark symptoms such as tremors, rigidity, and decreased movement. But groundbreaking new research appearing in the journal Nature Neuroscience is refuting that long-standing assumption. The roots of Parkinson's may not be in the brain at all, according to scientists from Wuhan University in China — they could be in the kidneys.

The new study, by a Wuhan University team in China, focuses on alpha-synuclein (α-Syn), a protein intimately associated with Parkinson's. Under normal conditions, α-Syn is involved in healthy neural function. But when it misfolds and aggregates, it becomes toxic and clumps together into Lewy bodies—Parkinson's and other related disease hallmarks.

This unexpected finding is based on an increasing amount of evidence that Parkinson's could start in peripheral organs and spread to the brain, as opposed to starting in the brain itself. The potential ramifications for early treatment, prevention, and detection are staggering.

According to the authors of the study, "We show that the kidney is a peripheral organ that is an origin of pathological α-Syn." Central to this research is a protein called alpha-synuclein (α-Syn) — already far and away with links to Parkinson's disease and other neurological disorders. In health, this protein is used in neuron function. But when it goes awry, it forms sticky clumps known as Lewy bodies, which disrupt brain function and are a hallmark of Parkinson's and dementia with Lewy bodies.

To reach their conclusion, the team performed a succession of very careful experiments. They studied kidney samples from individuals with Parkinson's and associated Lewy body dementias, as well as patients with chronic kidney disease (CKD) with no neurological symptoms. The results were dramatic: abnormal α-Syn growth was identified in the kidneys of 10 out of 11 individuals with Parkinson's or Lewy body dementia, and in 17 out of 20 CKD patients—even though these CKD patients had no evidence of disease in the brain during life.

What they discovered was astounding: Abnormal α-Syn deposits were found in 10 out of 11 Parkinson's or related disorder patients. But even more astonishing, 17 out of 20 CKD patients — with no known brain disorder — also exhibited early evidence of the same misfolded proteins in their kidneys.

This implies that protein clumping could start in the kidneys, many years before symptoms of neurological harm become evident. Traces of α-Syn pathology were also detected in regions of the brainstem and spinal cord in a few instances, again favoring the hypothesis of a kidney-to-brain route.

<h2>How Do the Kidneys Affect Parkinson's Risk?</h2>

The kidneys are not passive waste filters; they also actively remove α-Syn from the bloodstream. When kidney function is impaired, as in chronic kidney disease, this elimination process is defeated. The consequence is the accumulation of toxic proteins within the kidneys, which migrate to the brain and ultimately trigger the damage cascade causing Parkinson's.

This shift in paradigm is strengthened by epidemiological data. Massive research has revealed that individuals with compromised kidney function are at considerably greater risk of getting Parkinson's disease. The correlation is nonlinear, with increasing steepness in the risk as kidney function worsens.

<h2>Are There Multiple Triggers for Parkinson's?</h2>

This link between kidneys and brain doesn't imply the brain isn't involved in Parkinson's, but it doesn't exclude other causes either. Indeed, past studies have indicated that the gut might also be a place where α-Syn is accumulated and transmitted to the brain early on. The new research indicates Parkinson's could be a multi-system disorder, initiated by a range of causes and mechanisms—such as the kidneys, the gut, and possibly even the heart.

As the authors of the study point out, "Removal of α-Syn from the blood may hinder the progression of Parkinson's disease, providing new strategies for therapeutic management of Lewy body diseases."

<h2>Implications for Diagnosis and Treatment</h2>

The revelation that the kidneys could have a central role in Parkinson's offers both new hope for early detection and intervention. If α-Syn accumulation in the kidneys can be identified before neurological signs are apparent, it might be an early warning sign, enabling the possibility of preventive measures or early treatment.

In addition, treatments to enhance kidney function or facilitate clearance of α-Syn from the bloodstream may prove to be useful weapons in the battle against Parkinson's and other disorders. This strategy would complement current methods, which target preservation of the brain's dopamine-neurons.

Although the research is revolutionary, it isn't without its constraints. The human tissue sample was quite small, and though mice work well as models for human biology, they are not replicas.

Even so, the evidence is compelling enough to support more research. Subsequent studies with bigger human populations, improved imaging technology, and more comprehensive genetic analysis could replicate and build on these findings.

If confirmed, the kidney-brain link might be the missing piece of the Parkinson's puzzle — setting the stage for earlier diagnosis, tailored treatments, and even preventive medicine aimed at flushing out or blocking α-Syn in the kidneys and blood.

The kidneys could be a silent trigger for Parkinson's disease, with poisonous protein accumulation moving from the kidneys into the brain. Keeping kidneys healthy might be the key in the battle against neurodegenerative disorders.

Health Conditions A-Z

health

parkinsons disease

parkinsons disease origins

kidneys and parkinsons

alpha synuclein protein

lewy body disease

chronic kidney disease risk

parkinsons new research

kidney brain connection

Drinking Coffee Can Lower Your Risk Of Early Mortality With These 2 Changes

Do You Feel Drained No Matter How Much You Sleep And Rest?

Dementia Writing Test That Reveals Early Signs Of Cognitive Decline

Health News

Dishes With Fermented Foods To Eat For Your Gut Health

Yoga Poses That Stimulate Good Bowel Health

Weekend Warrior Exercises For Full Body Movement

Weekend Meal Prep Ideas That Will Last You A Weekend

Easy Homemade Healthy Dishes For Long Afternoons

Silent Walking: Mental Health Booster That Keeps You Fit

Dumbbell Exercises You Can Do At Home

These Foods Are Keeping You Awake At Night

Ways to Manage Sugar Cravings

Your Body Doesn’t Want You To Lose Weight – Here's It Resists

High-Protein No Cook Dishes You Should Try

Yoga Poses That Aid In Digestion

Low Calorie Dinner Options For Weight Loss

Cardiac Arrest Vs. Heart Attack: Difference Explained Under 60 Seconds

High Protein Low-Carb Snacks To Have On The Go

Knee Exercises Desk Workers Should Do For Joint Health

Why Do I Feel Sleepy During The Day?

High Protein Early Morning Meals To Keep You Full Till Lunch

International Yoga Day 2025: Benefits of Doing Tadasana Every Morning

High-Carb Foods That Are Really Healthy

Dementia Vs Alzheimer’s: Difference Explained Under 60 Seconds

Healthy Staple Foods To Make Eating Healthy Easier

Are You Dealing With Abandonment Issues? Signs And Risk Factors

Mid-Work Healthy Snacks You Can Eat Throughout The Day

Common Mistakes You May Be Making In The Gym

Strengthen Your Legs Muscles With These Exercises

Beat Anxiety With Books: How Reading Helps With Stress

Ghee For Health: Ayurvedic Health Benefits Of Clarified Butter

Common Mistakes You Are Making While Walking

Exercises You Should Do At Home When You Skip Gym

Common Mistakes You May Be Making While Working Out

Ways You Are Runing Your Weight Loss Journey

Beyond Fruits – How To Retain Hydration And Stay Safe In Summers

Can This Extremely Hot Weather Trigger Our Mental Health?

You Are Hurting Your Gut Health With These Habits

Avoid The Heat With These Indoor Exercises

Stay Sharp! Activities That Keep Cognitive Diseases At Bay

Protect Your Cardiovascular Health With These Heart Healthy Foods

Ways To Ease Nighttime Anxiety

Smoothie Ideas That Can Help With Weight Loss

For decades, Parkinson's disease has long been thought of as a brain disorder, characterized by the degeneration of dopamine-producing neurons in the substantia nigra — a region of the brain that regulates movement. The loss of these neurons progressively contributes to hallmark symptoms such as tremors, rigidity, and decreased movement. But groundbreaking new research appearing in the journal Nature Neuroscience is refuting that long-standing assumption. The roots of Parkinson's may not be in the brain at all, according to scientists from Wuhan University in China — they could be in the kidneys.The new study, by a Wuhan University team in China, focuses on alpha-synuclein (α-Syn), a protein intimately associated with Parkinson's. Under normal conditions, α-Syn is involved in healthy neural function. But when it misfolds and aggregates, it becomes toxic and clumps together into Lewy bodies—Parkinson's and other related disease hallmarks.This unexpected finding is based on an increasing amount of evidence that Parkinson's could start in peripheral organs and spread to the brain, as opposed to starting in the brain itself. The potential ramifications for early treatment, prevention, and detection are staggering.According to the authors of the study, "We show that the kidney is a peripheral organ that is an origin of pathological α-Syn." Central to this research is a protein called alpha-synuclein (α-Syn) — already far and away with links to Parkinson's disease and other neurological disorders. In health, this protein is used in neuron function. But when it goes awry, it forms sticky clumps known as Lewy bodies, which disrupt brain function and are a hallmark of Parkinson's and dementia with Lewy bodies.To reach their conclusion, the team performed a succession of very careful experiments. They studied kidney samples from individuals with Parkinson's and associated Lewy body dementias, as well as patients with chronic kidney disease (CKD) with no neurological symptoms. The results were dramatic: abnormal α-Syn growth was identified in the kidneys of 10 out of 11 individuals with Parkinson's or Lewy body dementia, and in 17 out of 20 CKD patients—even though these CKD patients had no evidence of disease in the brain during life.What they discovered was astounding: Abnormal α-Syn deposits were found in 10 out of 11 Parkinson's or related disorder patients. But even more astonishing, 17 out of 20 CKD patients — with no known brain disorder — also exhibited early evidence of the same misfolded proteins in their kidneys.This implies that protein clumping could start in the kidneys, many years before symptoms of neurological harm become evident. Traces of α-Syn pathology were also detected in regions of the brainstem and spinal cord in a few instances, again favoring the hypothesis of a kidney-to-brain route.How Do the Kidneys Affect Parkinson's Risk?The kidneys are not passive waste filters; they also actively remove α-Syn from the bloodstream. When kidney function is impaired, as in chronic kidney disease, this elimination process is defeated. The consequence is the accumulation of toxic proteins within the kidneys, which migrate to the brain and ultimately trigger the damage cascade causing Parkinson's.This shift in paradigm is strengthened by epidemiological data. Massive research has revealed that individuals with compromised kidney function are at considerably greater risk of getting Parkinson's disease. The correlation is nonlinear, with increasing steepness in the risk as kidney function worsens.Are There Multiple Triggers for Parkinson's?This link between kidneys and brain doesn't imply the brain isn't involved in Parkinson's, but it doesn't exclude other causes either. Indeed, past studies have indicated that the gut might also be a place where α-Syn is accumulated and transmitted to the brain early on. The new research indicates Parkinson's could be a multi-system disorder, initiated by a range of causes and mechanisms—such as the kidneys, the gut, and possibly even the heart.As the authors of the study point out, "Removal of α-Syn from the blood may hinder the progression of Parkinson's disease, providing new strategies for therapeutic management of Lewy body diseases."Implications for Diagnosis and TreatmentThe revelation that the kidneys could have a central role in Parkinson's offers both new hope for early detection and intervention. If α-Syn accumulation in the kidneys can be identified before neurological signs are apparent, it might be an early warning sign, enabling the possibility of preventive measures or early treatment.In addition, treatments to enhance kidney function or facilitate clearance of α-Syn from the bloodstream may prove to be useful weapons in the battle against Parkinson's and other disorders. This strategy would complement current methods, which target preservation of the brain's dopamine-neurons.Although the research is revolutionary, it isn't without its constraints. The human tissue sample was quite small, and though mice work well as models for human biology, they are not replicas.Even so, the evidence is compelling enough to support more research. Subsequent studies with bigger human populations, improved imaging technology, and more comprehensive genetic analysis could replicate and build on these findings.If confirmed, the kidney-brain link might be the missing piece of the Parkinson's puzzle — setting the stage for earlier diagnosis, tailored treatments, and even preventive medicine aimed at flushing out or blocking α-Syn in the kidneys and blood.The kidneys could be a silent trigger for Parkinson's disease, with poisonous protein accumulation moving from the kidneys into the brain. Keeping kidneys healthy might be the key in the battle against neurodegenerative disorders.

not from the brain, scientists trace parkinson’s disease to this organ in your body

Ishita Roy

Jenny Mollen Ends Up In ER After Microdosing GLP1 Medication

Health & Wellness

New ‘Exercise In A Pill’ Could Outperform Ozempic Without The Muscle Loss

new ‘exercise in a pill’ could outperform ozempic without the muscle loss

Feeling Miserable In The Heat? 5 Common Medications That May Be Putting You At Risk During Heatwaves

feeling miserable in the heat? 5 common medications that may be putting you at risk during heatwaves

Nutrition

Diagnostic Anomaly: If You Have This Disease, Your Body Will Forget To Tell You 'I Am Full'

if you have this disease, your body will forget to tell you "i am full"

This Juicy Fruit Might Actually Lower Your Diabetes Risk And Improve Insulin Sensitivity

surprising sweet fruit that you may be avoiding could better your insulin sensitivity and blood sugar levels

US TV Star, the 46-year-old <span>Jenny Mollen</span> was rushed to the Emergency Room due to a reaction that happened after she consumed the weight-loss drug, <span>GLP1</span> or the glucagon-like peptide-1 medication. 

In an Instagram story on June 26, she wrote, “I just posted a follow-up to my piece about <span>Tirzepatide</span> and microdosing. I had a lot of unanswered questions about it [that] just ironically got answered for me in the form of a trip to the ER two nights ago … I’m in such a f***ing haze. It’s been a crazy 48 hours.”

She also revealed that she lost one-fourth of her blood as she ended up in the hospital. 

Before we understand what is tirzepatide, it is important to understand how GLP1 medications work. It is a hormone naturally produced in the body that plays a role in regulating blood sugar levels and appetite. GLP-1 receptor agonists are a class of medications that mimic the effects of this hormone, used to treat type 2 diabetes and, increasingly, for weight management. 

Tirzepatide, on the other hand is a GLP1, like Ozempic or Wegovy. It regulates a person's blood sugar, appetite, and digestion. These medications are usually used to treat type 2 diabetes and obesity. 

Mollen, who is the wife of Jason Biggs, also wrote an essay, published on Substack, where she expressed her "growing concerns" about how the medication was affecting her “mentally.”

In her essay, she wrote: “I do think that in the coming years, we will hear more about how GLP1s cause depression, ruin marriages and rob us of our capacity for feeling joy. These drugs bind to our neurotransmitters, affecting levels of dopamine and serotonin. They change our relationship with food. And I believe they also change our relationship with people and ourselves.”

She also noted that why others may have a desire to use it, however, she expressed her concerns over how it could have a negative impact on individual’s mental health, as she also has her own first-hand experience. 

She further noted: “When I started Tirzepatide, the first thing I noticed was that I was crying more frequently. I couldn’t control the tears that would pour out of me when talking about subjects ranging from kids to open-faced tuna melts. I also noticed this underlying anxiety that would, without warning, after no more than one cup of espresso, take over my body and have me pacing in the kitchen like I’d just snorted an eightball of cocaine.”

She also noted that she would get irritated much quickly and she was “more easily offended and quicker to react” while she was on GLP1. 

She wrote: “I also began to sense that the joy and gratitude I once experienced, those moments of peak happiness, weren’t quite as intense as they used to be. I could feel the joy simmering beneath the surface, but it never reached the pinnacle it once had internally. Even on a rollercoaster, my sense of euphoria was dampened. I couldn’t feel the highs and lows. Satisfaction, personally and professionally, was just out of reach.”

jenny mollen

health news

GLP1

Jenny Mollen in ER

Jenny Mollen fat loss jab

Tirzepatide

US TV Star, the 46-year-old Jenny Mollen was rushed to the Emergency Room due to a reaction that happened after she consumed the weight-loss drug, GLP1 or the glucagon-like peptide-1 medication. In an Instagram story on June 26, she wrote, “I just posted a follow-up to my piece about Tirzepatide and microdosing. I had a lot of unanswered questions about it [that] just ironically got answered for me in the form of a trip to the ER two nights ago … I’m in such a f***ing haze. It’s been a crazy 48 hours.”She also revealed that she lost one-fourth of her blood as she ended up in the hospital. What Is Tirzepatide?Before we understand what is tirzepatide, it is important to understand how GLP1 medications work. It is a hormone naturally produced in the body that plays a role in regulating blood sugar levels and appetite. GLP-1 receptor agonists are a class of medications that mimic the effects of this hormone, used to treat type 2 diabetes and, increasingly, for weight management. Tirzepatide, on the other hand is a GLP1, like Ozempic or Wegovy. It regulates a person's blood sugar, appetite, and digestion. These medications are usually used to treat type 2 diabetes and obesity. What Happened To Mollen?Mollen, who is the wife of Jason Biggs, also wrote an essay, published on Substack, where she expressed her "growing concerns" about how the medication was affecting her “mentally.”In her essay, she wrote: “I do think that in the coming years, we will hear more about how GLP1s cause depression, ruin marriages and rob us of our capacity for feeling joy. These drugs bind to our neurotransmitters, affecting levels of dopamine and serotonin. They change our relationship with food. And I believe they also change our relationship with people and ourselves.”She also noted that why others may have a desire to use it, however, she expressed her concerns over how it could have a negative impact on individual’s mental health, as she also has her own first-hand experience. She further noted: “When I started Tirzepatide, the first thing I noticed was that I was crying more frequently. I couldn’t control the tears that would pour out of me when talking about subjects ranging from kids to open-faced tuna melts. I also noticed this underlying anxiety that would, without warning, after no more than one cup of espresso, take over my body and have me pacing in the kitchen like I’d just snorted an eightball of cocaine.”She also noted that she would get irritated much quickly and she was “more easily offended and quicker to react” while she was on GLP1. She wrote: “I also began to sense that the joy and gratitude I once experienced, those moments of peak happiness, weren’t quite as intense as they used to be. I could feel the joy simmering beneath the surface, but it never reached the pinnacle it once had internally. Even on a rollercoaster, my sense of euphoria was dampened. I couldn’t feel the highs and lows. Satisfaction, personally and professionally, was just out of reach.”

jenny mollen ends up in er after microdosing glp1 medication

Scientists Find Over 20 New Bat Viruses In China, Warn Of “Critical Implications”

How Did COVID-19 Begin? WHO Probe Still Can’t Identify The True Source

how did covid-19 begin? who probe still can’t identify the true source

Hepatitis A Outbreak In Europe: ECDC Confirms Over 2,000 Cases In Austria, Hungary, Czechia, Slovakia

hepatitis a outbreak in europe: ecdc confirms over 2,000 cases in austria, hungary, czechia, slovakia

Why Whooping Cough, Measles And Rubella Still Haunt U.S. Families, Here's What Vaccine Hesitancy Overlooks

why whooping cough, measles and rubella still haunt u.s. families, here's what vaccine hesitancy overlooks

The most deadly viruses in the world may be quietly fermenting in fruit orchards—literally over your head? You got it. In a finding that is generating high-profile buzz throughout the international scientific community, scientists in China have discovered over 20 novel bat viruses, some of which have close relatives to Hendra and Nipah—diseases with skull-chilling mortality rates and a track record of crossing over from animals to humans.

So what does this all mean to you, me, and the rest of the world? A new science study issued a warning to the global health community: scientists have found over 20 previously unknown viruses in Chinese Yunnan province bats. Two newly discovered henipaviruses closely related to the lethal Hendra and Nipah viruses are causing special concern because of their likely ability to cause human and animal disease. Health professionals caution that these discoveries have "critical implications" for global public health, highlighting an urgent need for increased surveillance and biosecurity protocols.

The discovery, reported in the journal PLOS Pathogens, has been sending shockwaves across the world's scientific and medical circles, with scientists alerting that the newly discovered viruses may have "critical implications" for global public health.

<h2>The Two Viruses That Have Experts Particularly on Edge</h2>

Two of the 22 viruses identified were particularly concerning: henipaviruses—a class of viruses with a reputation for being lethal. These were discovered in fruit bats that inhabit the vicinity of orchards and human habitations, a configuration that duplicates earlier outbreaks of Hendra virus in Australia. Among the viruses discovered in the study is the closest-known relative of the Hendra and Nipah viruses, which carry mortality rates of 40% to 80% in humans and are responsible for causing severe respiratory disease and brain inflammation.

What is more alarming is the transmission mode: both Hendra and Nipah viruses can also be transmitted via bat urine. In farming areas where bats scavenge in fruit farms, infected fruit can be used as a bridge for spillover into livestock—or humans.

"Academically, this is not a concern," replied Associate Professor Vinod Balasubramaniam, a virologist at Monash University's Malaysian campus. "This has practical implications, particularly for nations such as Australia where the ecology is shockingly similar."

<h2>Why Bats Are A Matter of Concern?</h2>

Bats have long been known to be the main hosts of viruses that are able to leap onto humans and animals, sometimes with catastrophic consequences. From Ebola to SARS, MERS, and most recently, the coronavirus causing COVID-19, bats are often suspected to be responsible for the appearance of new infectious diseases. Their own biology—long lifespan, social roosting habits, and strong immune systems—tends to make them perfect reservoirs for a vast range of viruses.

The emphasis of the new study on the kidneys is important. While most research to date has focused on bat saliva, feces, or blood, the kidneys might be important in viral shedding, especially by way of urine. This is particularly important for henipaviruses, which have been found to be excreted in bat urine and can infect fruit or surfaces and cause spillover to humans and animals.

Of all the viruses that have been found, the two new henipaviruses in fruit bats are of most concern to researchers. One of them is now known to be the closest-known relative of the Hendra and Nipah viruses—both of which have caused fatal outbreaks among humans and animals.

Hendra and Nipah viruses have the notorious reputation for high mortality rates, ranging from 40% to 80%. They induce severe brain inflammation (encephalitis) and respiratory illness, and can spread efficiently within populations of both humans and animals. In Australia alone, Hendra virus has caused 66 recorded outbreaks since 1994, killing four individuals and scores of horses. Nipah virus, on the other hand, has produced recurrent outbreaks in South and Southeast Asia, frequently associated with the consumption of fruit or fruit products contaminated by urine from bats.

The detection of henipaviruses closely related to each other in Yunnan's fruit bats—particularly those that inhabit orchards and villages—heightens the possibility of future spillover incidents. As Associate Professor Vinod Balasubramaniam of the Malaysian campus of Monash University points out, "The proximity between the Australian rural setting and Yunnan's orchards close to human dwellings emphasizes the need for heightened surveillance and biosecurity efforts."

Bats have come under closer scientific examination as natural reservoirs for most lethal viruses, including SARS, MERS, Ebola, and even SARS-CoV-2. This research is special because it targets the kidneys—a less often examined organ in virology studies.

Both Hendra and Nipah viruses can be spread by contact with bat urine. Fruit bats in agricultural environments tend to roost and feed in orchards near human habitation. When their urine gets onto fruit, the virus is consumed by livestock or human beings, paving the way for possible outbreaks.

This method of transmission is especially cause for alarm in areas where humans and animals are in close contact to bat habitats. As Dr. Alison Peel, a disease ecologist of wildlife at the University of Sydney, describes, these results indicate "potential opportunities for contact" with humans—particularly those in rural and peri-urban settings.

This research broadens our knowledge of the bat kidney infectome," scientists said. "It identifies the imperative zoonotic dangers lurking in plain sight and emphasizes the importance of complete-spectrum viral monitoring in understudied organs.

As per Dr. Yong Gao Peng, a virologist who participated in the research, "This finding does not mean an outbreak will be imminent. But it does show just how much we still don't know about the viral world within bats, and how important it is to chart it out comprehensively."

<h2>Why the World Should Pay Attention?</h2>

The detection of so many new bat viruses in a fairly small sample puts into perspective how much scientists actually still have yet to learn about the microbial universe borne by bats. As Dr. Yong Gao Peng, a virologist at Nias, cautions, "While the results are based on bat kidney samples and do not suggest impending outbreaks, they show how much we still don't know about the microbes bats carry."

In light of the past history of lethal outbreaks with bat-borne viruses, the stakes are obvious. Increased monitoring, particularly where bats and humans coexist in close proximity, is called for. The research also underscores the necessity of thorough investigations of hitherto less-studied organs—such as the kidneys—to fully evaluate the entire range of spillover threats.

"These viruses don't have to be pathogenic today," added Dr. Peel, "because viruses change. The take-home message here is the need for urgency in surveillance, especially in ecotones where humans, animals, and wildlife overlap."

Dr. Peng further contributes that the existence of such viruses, while localized to kidneys in this instance, is a sign from nature. "Most outbreaks are initiated by asymptomatic spillovers," he states. "Without timely detection and proper containment measures, they could quietly ferment into international crises."

This finding arrives as the globe is still fighting COVID-19 and wrestling with the advent of new infectious variants. Only 6% of Australian adults have been vaccinated with the new COVID-19 booster, as reported in national health figures. With the northern hemisphere preparing to face another winter surge, public health officials say complacency is not a choice.

virus in china

bat viruses china

new henipavirus discovery

zoonotic virus risk

hendra nipah relatives

plos bat virus study

bat kidney viruses

emerging infectious diseases

The most deadly viruses in the world may be quietly fermenting in fruit orchards—literally over your head? You got it. In a finding that is generating high-profile buzz throughout the international scientific community, scientists in China have discovered over 20 novel bat viruses, some of which have close relatives to Hendra and Nipah—diseases with skull-chilling mortality rates and a track record of crossing over from animals to humans.So what does this all mean to you, me, and the rest of the world? A new science study issued a warning to the global health community: scientists have found over 20 previously unknown viruses in Chinese Yunnan province bats. Two newly discovered henipaviruses closely related to the lethal Hendra and Nipah viruses are causing special concern because of their likely ability to cause human and animal disease. Health professionals caution that these discoveries have "critical implications" for global public health, highlighting an urgent need for increased surveillance and biosecurity protocols.The discovery, reported in the journal PLOS Pathogens, has been sending shockwaves across the world's scientific and medical circles, with scientists alerting that the newly discovered viruses may have "critical implications" for global public health.The Two Viruses That Have Experts Particularly on EdgeTwo of the 22 viruses identified were particularly concerning: henipaviruses—a class of viruses with a reputation for being lethal. These were discovered in fruit bats that inhabit the vicinity of orchards and human habitations, a configuration that duplicates earlier outbreaks of Hendra virus in Australia. Among the viruses discovered in the study is the closest-known relative of the Hendra and Nipah viruses, which carry mortality rates of 40% to 80% in humans and are responsible for causing severe respiratory disease and brain inflammation.What is more alarming is the transmission mode: both Hendra and Nipah viruses can also be transmitted via bat urine. In farming areas where bats scavenge in fruit farms, infected fruit can be used as a bridge for spillover into livestock—or humans."Academically, this is not a concern," replied Associate Professor Vinod Balasubramaniam, a virologist at Monash University's Malaysian campus. "This has practical implications, particularly for nations such as Australia where the ecology is shockingly similar."Why Bats Are A Matter of Concern?Bats have long been known to be the main hosts of viruses that are able to leap onto humans and animals, sometimes with catastrophic consequences. From Ebola to SARS, MERS, and most recently, the coronavirus causing COVID-19, bats are often suspected to be responsible for the appearance of new infectious diseases. Their own biology—long lifespan, social roosting habits, and strong immune systems—tends to make them perfect reservoirs for a vast range of viruses.The emphasis of the new study on the kidneys is important. While most research to date has focused on bat saliva, feces, or blood, the kidneys might be important in viral shedding, especially by way of urine. This is particularly important for henipaviruses, which have been found to be excreted in bat urine and can infect fruit or surfaces and cause spillover to humans and animals.The Henipavirus ThreatOf all the viruses that have been found, the two new henipaviruses in fruit bats are of most concern to researchers. One of them is now known to be the closest-known relative of the Hendra and Nipah viruses—both of which have caused fatal outbreaks among humans and animals.Hendra and Nipah viruses have the notorious reputation for high mortality rates, ranging from 40% to 80%. They induce severe brain inflammation (encephalitis) and respiratory illness, and can spread efficiently within populations of both humans and animals. In Australia alone, Hendra virus has caused 66 recorded outbreaks since 1994, killing four individuals and scores of horses. Nipah virus, on the other hand, has produced recurrent outbreaks in South and Southeast Asia, frequently associated with the consumption of fruit or fruit products contaminated by urine from bats.The detection of henipaviruses closely related to each other in Yunnan's fruit bats—particularly those that inhabit orchards and villages—heightens the possibility of future spillover incidents. As Associate Professor Vinod Balasubramaniam of the Malaysian campus of Monash University points out, "The proximity between the Australian rural setting and Yunnan's orchards close to human dwellings emphasizes the need for heightened surveillance and biosecurity efforts."How Do These Viruses Spread?Bats have come under closer scientific examination as natural reservoirs for most lethal viruses, including SARS, MERS, Ebola, and even SARS-CoV-2. This research is special because it targets the kidneys—a less often examined organ in virology studies.Both Hendra and Nipah viruses can be spread by contact with bat urine. Fruit bats in agricultural environments tend to roost and feed in orchards near human habitation. When their urine gets onto fruit, the virus is consumed by livestock or human beings, paving the way for possible outbreaks.This method of transmission is especially cause for alarm in areas where humans and animals are in close contact to bat habitats. As Dr. Alison Peel, a disease ecologist of wildlife at the University of Sydney, describes, these results indicate "potential opportunities for contact" with humans—particularly those in rural and peri-urban settings.This research broadens our knowledge of the bat kidney infectome," scientists said. "It identifies the imperative zoonotic dangers lurking in plain sight and emphasizes the importance of complete-spectrum viral monitoring in understudied organs.As per Dr. Yong Gao Peng, a virologist who participated in the research, "This finding does not mean an outbreak will be imminent. But it does show just how much we still don't know about the viral world within bats, and how important it is to chart it out comprehensively."Why the World Should Pay Attention?The detection of so many new bat viruses in a fairly small sample puts into perspective how much scientists actually still have yet to learn about the microbial universe borne by bats. As Dr. Yong Gao Peng, a virologist at Nias, cautions, "While the results are based on bat kidney samples and do not suggest impending outbreaks, they show how much we still don't know about the microbes bats carry."In light of the past history of lethal outbreaks with bat-borne viruses, the stakes are obvious. Increased monitoring, particularly where bats and humans coexist in close proximity, is called for. The research also underscores the necessity of thorough investigations of hitherto less-studied organs—such as the kidneys—to fully evaluate the entire range of spillover threats."These viruses don't have to be pathogenic today," added Dr. Peel, "because viruses change. The take-home message here is the need for urgency in surveillance, especially in ecotones where humans, animals, and wildlife overlap."Dr. Peng further contributes that the existence of such viruses, while localized to kidneys in this instance, is a sign from nature. "Most outbreaks are initiated by asymptomatic spillovers," he states. "Without timely detection and proper containment measures, they could quietly ferment into international crises."This finding arrives as the globe is still fighting COVID-19 and wrestling with the advent of new infectious variants. Only 6% of Australian adults have been vaccinated with the new COVID-19 booster, as reported in national health figures. With the northern hemisphere preparing to face another winter surge, public health officials say complacency is not a choice.

scientists find over 20 new bat viruses in china, warn of “critical implications”

India’s Drug Regulator Flags 186 Medicines For Failing Quality Test, Paracetamol And Diabetes Meds Included

This New Blood Test Could Spot Leukemia Risk Without The Painful Bone Marrow Sampling

this new blood test could spot leukemia risk without the painful bone marrow sampling

One Crucial Habit Every Diabetic Is Forgetting – And It Starts With Your Toothbrush

one crucial habit every diabetic is forgetting – and it starts with your toothbrush

In a significant development that highlights the increasing scrutiny over the safety of pharma products, India's Central Drugs Standard Control Organisation (CDSCO) has identified 186 drugs and formulations as Not of Standard Quality (NSQ) in its surveillance report for May 2025. These identified drugs encompass widely prescribed drugs like paracetamol as well as diabetes drugs, triggering grave concerns over the safety of drugs in one of the world's largest pharmaceutical markets.

The action, the CDSCO says, is its part of regular regulatory vigilance aimed at detecting and eliminating unsafe drugs in the market so that patients are not inadvertently left consuming substandard or spurious medicines.

The list, published by the country's national drug regulator on 27 June, 2025, contains common drugs like paracetamol and insulin used to treat diabetes, prompting critical questions on drug safety, regulatory scrutiny, and public health in one of the biggest pharma markets in the world.

The CDSCO's recent warning follows central and state drug testing laboratories in India reporting scores of samples from pharmacies and distribution centers across the country. Of the total 186 failed quality test samples, 128 were detected by state drug testing laboratories, and 58 by central labs. All this aggressive monitoring forms part of CDSCO's constant vigilance to ensure the quality of drugs being sold to Indian consumers.

Of the 186 substandard drug samples, 128 were identified by state drug testing labs and 58 by central labs, as per the official notification. All these drugs failed one or more of the quality parameters such as potency, dissolution rate, microbial load, or content uniformity, and hence were not fit for use by patients.

In a statement that released with the move, CDSCO sought to point out that one failed batch of drug is unique to that batch and does not always mean all batches of the same brand or product are unsafe. Still, the detection of even a single poor batch can have implications for public health, particularly in the case of life-saving and chronic disease drugs.

The CDSCO also established that two of the Bihar drug samples were spurious, i.e., produced by unauthorized parties with the brand name of a different licensed company. These results suggest counterfeit operations in India's huge and intricate drug distribution system.

The regulator has assured that the incidents are being investigated and action would be taken under the Drugs and Cosmetics Act and the accompanying rules.

This is not a one-off case. CDSCO reported 900 samples as substandard and 20 as spurious in the year 2024 alone, all of them selected from pharmacies, hospitals, and distribution outlets throughout the nation.

<h2>What Are "Not of Standard Quality" (NSQ) and Spurious Drugs?</h2>

CDSCO defines NSQ as an occurrence of failure to satisfy one or more of the stipulated quality parameters during laboratory testing. The parameters would involve potency, purity, dissolution, and contaminants or impurities. Significantly, the regulator points out that a failed batch does not necessarily incriminate all the products of the same brand or company.

Aside from NSQ medicines, the CDSCO also marked two samples from the state of Bihar as "spurious." These were discovered to have been produced by illegal manufacturers with the use of the brand name of another firm—a grave offense which is being investigated. Adulterated and spurious medicines are especially threatening since they can have the wrong or harmful ingredients and therefore directly threaten patient safety. 

<h2>How India Monitors Drug Quality?</h2>

India's pharma industry is one of the biggest in the world, serving not just the domestic market but also exports to more than 200 nations. With such a huge market, maintaining drug safety is no small effort. The CDSCO, along with state regulators, regularly takes drug samples from sales and distribution points. The samples are tested thoroughly in the laboratory, and the findings are made available on the CDSCO portal on a monthly basis.

This openness achieves several functions: it warns medical professionals and the general public to possible danger, raises responsibility on manufacturers, and preserves the level of trust for the healthcare system. In the words of Dr. Rajeev Singh Raghuvanshi, India's Drugs Controller General, only roughly 1.5% of drugs tested in recent surveys turned out to be less effective, indicating that the overwhelming majority of medicines available are safe. Still, a small proportion can add up to potentially great public health threats in view of India's population and the magnitude of drug use.

<h2>Threats to Public Health and World Drug Supply</h2>

India has been commonly referred to as the "pharmacy of the world," exporting generic drugs to more than 200 nations. Any quality lapse not only impacts Indian consumers but also tarnishes world confidence in Indian pharmaceuticals. Paracetamol and anti-diabetics are consumed by millions — any compromise on their effectiveness or safety can be devastating health-wise.

Substandard or counterfeit drugs are one of the greatest dangers to contemporary medicine," an independent pharmacovigilance expert in New Delhi said. "They may not treat the disease, may worsen patient outcomes, or lead to antimicrobial resistance."

The public, clinicians, and policymakers need to address CDSCO notifications not as run-of-the-mill bureaucracy but as canary-in-the-coal-mines warnings of broader systemic problems in manufacturing regulation, supply chain integrity, and quality control procedures.

<h2>What Can Healthcare Providers and Patients Do?</h2>

Awareness is the best defense for patients. The CDSCO's medicine alert system seeks to inform consumers and healthcare providers about possible dangers of certain drugs. Patients must go see their doctors or pharmacists if they have issues with their medication and avoid buying drugs from unofficial sources.

Healthcare professionals, on their part, must remain up to date on the current CDSCO reports and advisories, particularly when dispensing or prescribing high-risk drugs. Keeping an eye on the CDSCO portal regularly and being subscribed to alerts can help ensure that patients receive only safe and effective medicines. Patients must:

<ul><li>Inquire about the batch number and manufacturer prior to taking prescribed drugs.</li><li>Immediately report any side effects.</li><li>Do not buy drugs from illegal online pharmacies.</li></ul>

In addition, hospitals and states should institutionalize pharmacovigilance programs in order to identify adverse trends early.

The CDSCO's forward-looking attitude—constant vigilance, open reporting, and rapid enforcement against violators—is reflective of India's seriousness in protecting public health. Nevertheless, the challenge persists. As the pharmaceutical sector continues its expansion, so must regulatory capability, laboratory facilities, and public awareness.

banned medicines in india

cdsco drug alert 2025

substandard medicines india

paracetamol quality issue

diabetes drug recall

spurious drugs india

nsq drug list cdsco

india drug safety news

In a significant development that highlights the increasing scrutiny over the safety of pharma products, India's Central Drugs Standard Control Organisation (CDSCO) has identified 186 drugs and formulations as Not of Standard Quality (NSQ) in its surveillance report for May 2025. These identified drugs encompass widely prescribed drugs like paracetamol as well as diabetes drugs, triggering grave concerns over the safety of drugs in one of the world's largest pharmaceutical markets.The action, the CDSCO says, is its part of regular regulatory vigilance aimed at detecting and eliminating unsafe drugs in the market so that patients are not inadvertently left consuming substandard or spurious medicines.The list, published by the country's national drug regulator on 27 June, 2025, contains common drugs like paracetamol and insulin used to treat diabetes, prompting critical questions on drug safety, regulatory scrutiny, and public health in one of the biggest pharma markets in the world.The CDSCO's recent warning follows central and state drug testing laboratories in India reporting scores of samples from pharmacies and distribution centers across the country. Of the total 186 failed quality test samples, 128 were detected by state drug testing laboratories, and 58 by central labs. All this aggressive monitoring forms part of CDSCO's constant vigilance to ensure the quality of drugs being sold to Indian consumers.Of the 186 substandard drug samples, 128 were identified by state drug testing labs and 58 by central labs, as per the official notification. All these drugs failed one or more of the quality parameters such as potency, dissolution rate, microbial load, or content uniformity, and hence were not fit for use by patients.In a statement that released with the move, CDSCO sought to point out that one failed batch of drug is unique to that batch and does not always mean all batches of the same brand or product are unsafe. Still, the detection of even a single poor batch can have implications for public health, particularly in the case of life-saving and chronic disease drugs.The CDSCO also established that two of the Bihar drug samples were spurious, i.e., produced by unauthorized parties with the brand name of a different licensed company. These results suggest counterfeit operations in India's huge and intricate drug distribution system.The regulator has assured that the incidents are being investigated and action would be taken under the Drugs and Cosmetics Act and the accompanying rules.This is not a one-off case. CDSCO reported 900 samples as substandard and 20 as spurious in the year 2024 alone, all of them selected from pharmacies, hospitals, and distribution outlets throughout the nation.What Are "Not of Standard Quality" (NSQ) and Spurious Drugs?CDSCO defines NSQ as an occurrence of failure to satisfy one or more of the stipulated quality parameters during laboratory testing. The parameters would involve potency, purity, dissolution, and contaminants or impurities. Significantly, the regulator points out that a failed batch does not necessarily incriminate all the products of the same brand or company.Aside from NSQ medicines, the CDSCO also marked two samples from the state of Bihar as "spurious." These were discovered to have been produced by illegal manufacturers with the use of the brand name of another firm—a grave offense which is being investigated. Adulterated and spurious medicines are especially threatening since they can have the wrong or harmful ingredients and therefore directly threaten patient safety. How India Monitors Drug Quality?India's pharma industry is one of the biggest in the world, serving not just the domestic market but also exports to more than 200 nations. With such a huge market, maintaining drug safety is no small effort. The CDSCO, along with state regulators, regularly takes drug samples from sales and distribution points. The samples are tested thoroughly in the laboratory, and the findings are made available on the CDSCO portal on a monthly basis.This openness achieves several functions: it warns medical professionals and the general public to possible danger, raises responsibility on manufacturers, and preserves the level of trust for the healthcare system. In the words of Dr. Rajeev Singh Raghuvanshi, India's Drugs Controller General, only roughly 1.5% of drugs tested in recent surveys turned out to be less effective, indicating that the overwhelming majority of medicines available are safe. Still, a small proportion can add up to potentially great public health threats in view of India's population and the magnitude of drug use.Threats to Public Health and World Drug SupplyIndia has been commonly referred to as the "pharmacy of the world," exporting generic drugs to more than 200 nations. Any quality lapse not only impacts Indian consumers but also tarnishes world confidence in Indian pharmaceuticals. Paracetamol and anti-diabetics are consumed by millions — any compromise on their effectiveness or safety can be devastating health-wise.Substandard or counterfeit drugs are one of the greatest dangers to contemporary medicine," an independent pharmacovigilance expert in New Delhi said. "They may not treat the disease, may worsen patient outcomes, or lead to antimicrobial resistance."The public, clinicians, and policymakers need to address CDSCO notifications not as run-of-the-mill bureaucracy but as canary-in-the-coal-mines warnings of broader systemic problems in manufacturing regulation, supply chain integrity, and quality control procedures.What Can Healthcare Providers and Patients Do?Awareness is the best defense for patients. The CDSCO's medicine alert system seeks to inform consumers and healthcare providers about possible dangers of certain drugs. Patients must go see their doctors or pharmacists if they have issues with their medication and avoid buying drugs from unofficial sources.Healthcare professionals, on their part, must remain up to date on the current CDSCO reports and advisories, particularly when dispensing or prescribing high-risk drugs. Keeping an eye on the CDSCO portal regularly and being subscribed to alerts can help ensure that patients receive only safe and effective medicines. Patients must:Inquire about the batch number and manufacturer prior to taking prescribed drugs.Immediately report any side effects.Do not buy drugs from illegal online pharmacies.In addition, hospitals and states should institutionalize pharmacovigilance programs in order to identify adverse trends early.The CDSCO's forward-looking attitude—constant vigilance, open reporting, and rapid enforcement against violators—is reflective of India's seriousness in protecting public health. Nevertheless, the challenge persists. As the pharmaceutical sector continues its expansion, so must regulatory capability, laboratory facilities, and public awareness.

india’s drug regulator flags 186 medicines for failing quality test, paracetamol and diabetes meds included

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.